» Articles » PMID: 23130165

Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients

Overview
Date 2012 Nov 7
PMID 23130165
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrial fibrillation (AF) and chronic kidney disease (CKD) are prevalent in the elderly and are independently associated with increased risk of death. We evaluated risk of incident AF with advancing CKD and examined the mortality rate associated with CKD after incident AF in elderly patients.

Methods And Results: This retrospective cohort study used the Medicare 5% database. Point-prevalent Medicare enrollees on December 31, 2006, without preexistent AF or end-stage renal disease were followed up for incident AF through 2008. CKD and AF were identified from International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Associations between CKD stage and incident AF and subsequent risk of death were examined in a Cox proportional-hazards model. Unadjusted survival after incident AF was estimated by the Kaplan-Meier method. CKD was present in 55 962 patients (5.1% of the cohort). Of these, 4952 (8.8%) had CKD stages 1 and 2; 19 795 (35.3%), stages 3 to 5; and 31 215 (55.7%), unknown stage. The hazard ratio for incident AF in CKD stages 3 to 5 was 1.13 (95% confidence interval 1.09 to 1.18). Other stages were not independently associated with incident AF. Survival after incident AF decreased progressively as CKD stage increased (P<0.0001). The 1-year mortality rate for CKD stages 3 to 5 with incident AF was 35.6%. Adjusted hazard ratios for death after incident AF were 1.14 (95% confidence interval 1.00 to 1.30) for CKD stages 1 and 2, 1.27 (95% confidence interval 1.20 to 1.35) for CKD stages 3 to 5, and 1.29 (95% confidence interval 1.23 to 1.36) for unknown stage.

Conclusions: Advanced CKD is associated with increased risk of incident AF. In Medicare patients with incident AF, mortality rates are higher for those with advanced CKD than for those without CKD. (J Am Heart Assoc. 2012;1:e002097 doi: 10.1161/JAHA.112.002097.).

Citing Articles

Association between life's essential 8 and Parkinson's disease: a case-control study.

Fan J, Wang Y, Guo X, Cao S, Zhan S, Li R BMC Public Health. 2025; 25(1):411.

PMID: 39893440 PMC: 11786534. DOI: 10.1186/s12889-025-21648-0.


Atrial fibrillation: comorbidities, lifestyle, and patient factors.

Shantsila E, Choi E, Lane D, Joung B, Lip G Lancet Reg Health Eur. 2024; 37:100784.

PMID: 38362547 PMC: 10866737. DOI: 10.1016/j.lanepe.2023.100784.


Anticoagulation in Patients with Chronic Kidney Disease.

Elenjickal E, Travlos C, Marques P, Mavrakanas T Am J Nephrol. 2023; 55(2):146-164.

PMID: 38035566 PMC: 10994631. DOI: 10.1159/000535546.


Prevalence and Factors Associated with Atrial Fibrillation in Patients with Transient Ischemic Attack or Ischemic Stroke in Northern Vietnam.

Phong P, Tung B, Hung P, Quang N, Hoai N, Viet Dung N J Clin Med. 2023; 12(17).

PMID: 37685583 PMC: 10488041. DOI: 10.3390/jcm12175516.


Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study.

Kim S, Jeong Y, Kim Y, Kang M, Kang E, Ryu H J Am Heart Assoc. 2023; 12(8):e028496.

PMID: 37066806 PMC: 10227274. DOI: 10.1161/JAHA.122.028496.


References
1.
Lakshminarayan K, Solid C, Collins A, Anderson D, Herzog C . Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke. 2006; 37(8):1969-74. DOI: 10.1161/01.STR.0000230607.07928.17. View

2.
Raymond N, Zehnder D, Smith S, Stinson J, Lehnert H, Higgins R . Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant. 2007; 22(11):3214-20. DOI: 10.1093/ndt/gfm396. View

3.
Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

4.
Ehrlich J, Hohnloser S, Nattel S . Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2005; 27(5):512-8. DOI: 10.1093/eurheartj/ehi668. View

5.
Schlaich M, Socratous F, Hennebry S, Eikelis N, Lambert E, Straznicky N . Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2008; 20(5):933-9. DOI: 10.1681/ASN.2008040402. View